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Smad4 is an important mediator of signaling by TGFβ family members that is presumed to be 
controlled by the phosphorylation status of its partners, the receptor-regulated R-Smads. In this 
issue, Dupont et al. (2009) now reveal that Smad4 itself is subject to cycles of ubiquitination and 
deubiquitination that regulate its interactions with the R-Smads.It was 14 years ago that Smads were 
first discovered to be key intracel-
lular mediators of the transcriptional 
responses to transforming growth 
factor-β (TGFβ). TGFβ is the founding 
member of a large group of secreted 
factors that control virtually every 
developmental process as well as 
homeostasis in the adult. Disturbances 
in TGFβ signaling are thus associated 
with a host of developmental disorders 
and complex diseases such as can-
cer. Soon after the initial description of 
Smads in the fruit fly Drosophila mela-
nogaster and the worm Caenorhabdi-
tis elegans, it was quickly realized that 
Smads transmit signals directly from 
the TGFβ receptor kinase complex to 
the nucleus where they mediate tran-
scriptional responses. There are only 
eight Smads in mammals, and they are 
subdivided into three distinct classes: 
the receptor-regulated or R-Smads 
comprised of Smads 1, 2, 3, 5, and 8; 
the common Smad called co-Smad4; 
and finally two inhibitory I-Smads, 
Smads 6 and 7. Smads communicate 
most effectively if they gather in com-
plexes, an event that is driven by phos-
phorylation of R-Smads. The best-
studied Smad complex is that formed 
between phosphorylated R-Smads 
and Smad4 (Figure 1). Although Smad4 
is not obligatory for TGFβ signaling, 
it is required to provide the highest 
response to signaling. This is read-
ily explained by the fact that Smad4 
stabilizes Smad DNA-binding com-
plexes and also recruits transcriptional 
coactivators such as histone acetyl-
transferases to regulatory elements. 
Despite the elegant simplicity of this 
core pathway, Smads regulate a dizzy-
ing array of transcriptional responses to TGFβ family members. They do this 
in a surprising way: by trading in high-
affinity and high-specificity DNA-bind-
ing activity in exchange for promiscu-
ous protein-protein interactions with a 
wide range of transcription factors. By 
depending on the cell’s repertoire of 
DNA-binding partners to direct them to 
the right regulatory elements, Smads 
are thus admirably suited to mediate 
responses to TGFβ that are exquisitely 
context dependent.
All of this nicely explains how TGFβ 
family members control cell fate choices 
in so many different developmental Cell 1and homeostatic processes. But TGFβ 
target genes are also very dynamic in 
vivo, suggesting that turning off Smads 
may be just as important as turning 
them on. Smads undergo constant 
nucleocytoplasmic shuttling, and their 
assembly into complexes drives inter-
actions with the transcriptional regula-
tor TAZ, which in turn results in reten-
tion of Smads in the nucleus (Varelas 
et al., 2008). So the key to turning off 
Smads lies in regulating disassembly 
of the Smad complex in the nucleus. 
One obvious way to do that would be 
to target R-Smads for dephosphoryla-Figure 1. Regulation of the Smad Complex by Ubiquitin
Stimulation of R-Smad phosphorylation by the TGFβ receptor kinase induces assembly of a heteromeric 
complex between R-Smads and Smad4, which accumulates in the nucleus. Interaction of this complex 
with Ecto/TIF1γ in the nucleus leads to dissociation of Smad4 and its monoubiquitination. Through activ-
ity of the deubiquitinase FAM/USP9x in the cytoplasm Smad4 is deubiquitinated and is returned to the 
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tion by phosphatases (Moorhead et al., 
2007). Although prior work on switch-
ing off Smad complexes has focused 
exclusively on R-Smads, in this issue 
Dupont et al. (2009) now report that the 
long-ignored Smad4 has been leading 
an exciting secret life. These research-
ers show that monoubiquitination and 
deubiquitination of Smad4 play a key 
role in the assembly and disassembly 
of the Smad complex (Figure 1).
Ubiquitin and Smads are no strang-
ers as Smads are subject to ubiquitin-
dependent degradation, help to direct 
ubiquitin ligases to their targets, and 
directly control ubiquitin ligase activity 
(Izzi and Attisano, 2004). The ubiquitin 
ligase studied by Dupont et al. (2009) 
is a protein called Ectodermin (Ecto) 
or TIF1γ, which is a nuclear-localized 
TRIM family protein belonging to the 
RING class of ubiquitin ligases. Dupont 
et al. (2005) first identified Ectodermin 
as a regulator of TGFβ signaling in a 
screen for ectoderm determinants dur-
ing gastrulation in vertebrates. They 
suggested that Ecto/TIF1γ antagonized 
TGFβ signaling by regulating ubiquitin-
dependent degradation of Smad4. 
Subsequent work, however, showed 
that Ecto/TIF1γ also bound to R-Smad 
complexes, interfering with their bind-
ing to co-Smad4 and thereby direct-
ing a Smad4-independent signal that 
regulates the erythroid differentiation 
of human hematopoietic stem cells 
(He et al., 2006). Although these stud-
ies propose different mechanisms of 
action for Ecto/TIF1γ, they all suggest 
that TIF1γ serves to antagonize Smad4. 
In their new study, Dupont et al. (2009) 
now introduce a revised proposal that 
Ecto/TIF1γ antagonizes Smad signal-
ing by directing monoubiquitination 
of Smad4 in the nucleus. This would 
serve to break up the heteromeric 
R-Smad-Smad4 complex, blocking 
signaling and releasing monoubiquit-
inated Smad4.
However, this is only the beginning. 
Because monoubiquitination is a revers-
ible process, Dupont et al. pursued a 
focused RNAi screen to identify poten-
tial deubiquitinases that might serve to 
release monoubiquitin from Smad4 and 
direct it back to the signaling pathway. 14 Cell 136, January 9, 2009 ©2009 ElsevieThis led them to the discovery of the 
deubiquitinase FAM/USP9x. FAM was 
first discovered in the fly, where it is 
called fat facets (FAM stands for fat fac-
ets in mouse). FAM regulates β-catenin 
stability and Notch signaling and has 
been linked to endocytic pathways 
that control the activity of Epsin, a key 
regulator of trafficking (Carthew and Xu, 
2000). Dupont et al. (2009) now demon-
strate that FAM deubiquitinates Smad4 
that has been monoubiquitinated by 
Ecto/TIF1γ. As ubiquitination of Smad4 
leads to disassembly of the Smad com-
plex, the outcome of FAM deubiquit-
ination is release of Smad4 back into 
the TGFβ signaling pool. Smad4 thus 
engages in cycles of ubiquitination that 
can serve to regulate assembly of the 
R-Smad-Smad4 complex. Accordingly, 
the authors find that Smad4-dependent 
signaling in mammalian cell lines and in 
the gastrulating frog embryo is depen-
dent on FAM.
They also examined signaling by the 
TGFβ factor DPP in fly wings. Flies do 
not have Ecto/TIF1γ, but the investiga-
tors show that overexpression of Ecto/
TIF1γ antagonizes DPP-dependent for-
mation of crossveins and that this is 
reversed by FAM. Unleashing the pow-
erful genetics available in the fly should 
now allow exploration of whether the 
endogenous fly FAM gene, fat facets, 
regulates Smad signaling. One place 
in the fly where fat facets may function 
is at the neuromuscular junction where 
bone morphogenetic proteins (BMPs) 
regulate growth and stabilization of 
the synapse (Marques et al., 2002). 
The ubiquitin ligase Highwire, which is 
also of the RING class, opposes BMP 
function in this pathway and binds 
to Medea, the fly Smad4 ortholog 
(McCabe et al., 2004). Highwire may 
thus provide Ecto/TIF1γ-like activity 
in this pathway. Moreover, in an inde-
pendent study, fat facets was shown to 
antagonize Highwire (DiAntonio et al., 
2001). Based on the studies of Dupont 
et al., it is thus tempting to speculate 
that fat facets may be acting in part to 
promote BMP signaling and synaptic 
growth by preventing Highwire-depen-
dent targeting of Medea. Furthermore, 
although the Dupont et al. study points r Inc.to FAM as a positive regulator of Smad 
function, it has yet to be seen whether 
FAM might antagonize erythroid differ-
entiation, which is mediated by Smad2-
TIF1γ complexes.
FAM has now emerged as a fascinating 
protein that can regulate the activity of a 
number of signaling pathways, including 
those of Notch and potentially Wnt, via 
stabilization of β-catenin. Further, FAM 
is a regulator of endocytic trafficking, in 
particular of the adaptor Epsin (called 
liquid facets in the fly) (Carthew and Xu, 
2000). Cycling of ubiquitin in these other 
pathways may resemble that in Dupont 
et al.’s model for Smad4, suggesting 
that FAM sits at the center of multiple 
ubiquitin regulatory networks. The new 
work by Dupont et al. suggests the excit-
ing possibility that like phosphorylation, 
ubiquitination cycles play key roles in 
controlling the dynamic assemblies of 
protein interaction networks that under-
lie all signal transduction pathways.
ReFeRenCeS
Carthew, R.W., and Xu, C. (2000). Curr. Biol. 10, 
R532–R534.
DiAntonio, A., Haghighi, A.P., Portman, S.L., Lee, 
J.D., Amaranto, A.M., and Goodman, C.S. (2001). 
Nature 412, 449–452.
Dupont, S., Zacchigna, L., Cordenonsi, M., Soligo, 
S., Adorno, M., Rugge, M., and Piccolo, S. (2005). 
Cell 121, 87–99.
Dupont, S., Mamidi, A., Cordenonsi, M., Mon-
tagner, M., Zacchigna, L., Adorno, M., Martello, 
G., Stinchfield, M.J., Soligo, S., Morsut, L., et al. 
(2009). Cell, this issue.
He, W., Dorn, D.C., Erdjument-Bromage, H., 
Tempst, P., Moore, M.A., and Massague, J. (2006). 
Cell 125, 929–941.
Izzi, L., and Attisano, L. (2004). Oncogene 23, 
2071–2078.
Marques, G., Bao, H., Haerry, T.E., Shimell, M.J., 
Duchek, P., Zhang, B., and O’Connor, M.B. (2002). 
Neuron 33, 529–543.
McCabe, B.D., Hom, S., Aberle, H., Fetter, R.D., 
Marques, G., Haerry, T.E., Wan, H., O’Connor, 
M.B., Goodman, C.S., and Haghighi, A.P. (2004). 
Neuron 41, 891–905.
Moorhead, G.B., Trinkle-Mulcahy, L., and Ulke-
Lemee, A. (2007). Nat. Rev. Mol. Cell Biol. 8, 
234–244.
Varelas, X., Sakuma, R., Samavarchi-Tehrani, P., 
Peerani, R., Rao, B.M., Dembowy, J., Yaffe, M.B., 
Zandstra, P.W., and Wrana, J.L. (2008). Nat. Cell 
Biol. 10, 837–848.
